ArticleCardiovascular endocrinology & metabolism2023

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis.

Radhika Deshpande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.